BrightSpring raises 2026 revenue, EBITDA guidance
BrightSpring posted Q3 2026 results with significant revenue and profit growth, driven by Pharmacy and Provider segments, and increased full year revenue and adjusted EBITDA outlook.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed